Lambda Light Chain Cast Nephropathy Caused by Splenic Marginal Zone Lymphoma

Joyce H Gu1, Nicholas Smothermon2, Jusnimrat Kohli2

  • 1Medicine, Lake Erie College of Osteopathic Medicine, Greensburg, USA.

Cureus
|January 20, 2025
PubMed

Insights

This case study details a patient with splenic marginal zone lymphoma who developed kidney injury due to light chain cast nephropathy. This rare complication highlights a serious risk associated with certain lymphomas.

Area of Science:

  • Hematology
  • Nephrology
  • Oncology

Background:

  • Splenic marginal zone lymphoma (SMZL) is a rare B-cell lymphoma.
  • Monoclonal gammopathy can indicate underlying plasma cell disorders or lymphoproliferative diseases.
  • Renal injury in lymphoma patients can stem from various mechanisms, including direct infiltration or paraneoplastic syndromes.

Observation:

  • An elderly male patient presented with symptoms of renal injury.
  • Diagnostic workup revealed monoclonal gammopathy with elevated free lambda light chains.
  • Bone marrow biopsy excluded multiple myeloma, while renal biopsy confirmed lambda light chain cast nephropathy.

Findings:

  • The patient had splenic marginal zone lymphoma with monoclonal CD5+ B cells.
  • Lambda light chain cast nephropathy was identified as the cause of renal failure.
  • Despite interventions, the patient's condition worsened, leading to expiration.

Implications:

  • This case underscores light chain cast nephropathy as a critical and rare complication of lymphomas.
  • It emphasizes the importance of considering renal pathology in lymphoma patients with declining kidney function.
  • Early recognition and management of light chain nephropathy may improve outcomes in lymphoma patients.